Literature DB >> 35230204

The application of precision medicine in monogenic diabetes.

Fabrizio Barbetti1,2, Novella Rapini2, Riccardo Schiaffini2, Carla Bizzarri2, Stefano Cianfarani3,4,5.   

Abstract

INTRODUCTION: Monogenic diabetes, a form of diabetes mellitus, is caused by a mutation in a single gene and may account for 1-2% of all clinical forms of diabetes. To date, more than 40 loci have been associated with either isolated or syndromic monogenic diabetes. AREAS COVERED: While the request of a genetic test is mandatory for cases with diabetes onset in the first 6 months of life, a decision may be difficult for childhood or adolescent diabetes. In an effort to assist the clinician in this task, we have grouped monogenic diabetes genes according to the age of onset (or incidental discovery) of hyperglycemia and described the additional clinical features found in syndromic diabetes. The therapeutic options available are reviewed. EXPERT OPINION: Technical improvements in DNA sequencing allow for rapid, simultaneous analysis of all genes involved in monogenic diabetes, progressively shrinking the area of unsolved cases. However, the complexity of the analysis of genetic data requires close cooperation between the geneticist and the diabetologist, who should play a proactive role by providing a detailed clinical phenotype that might match a specific disease gene.

Entities:  

Keywords:  B cell; genetics; monogenic diabetes; neonatal diabetes; syndromic diabetes

Mesh:

Year:  2022        PMID: 35230204     DOI: 10.1080/17446651.2022.2035216

Source DB:  PubMed          Journal:  Expert Rev Endocrinol Metab        ISSN: 1744-6651


  2 in total

1.  Search for a time- and cost-saving genetic testing strategy for maturity-onset diabetes of the young.

Authors:  Petra Dusatkova; Marketa Pavlikova; Lenka Elblova; Vladyslav Larionov; Klara Vesela; Katerina Kolarova; Zdenek Sumnik; Jan Lebl; Stepanka Pruhova
Journal:  Acta Diabetol       Date:  2022-06-23       Impact factor: 4.087

2.  Early-Onset Diabetes in an Infant with a Novel Frameshift Mutation in LRBA.

Authors:  Alessio Galati; Rosalia Muciaccia; Antonella Marucci; Rosa Di Paola; Claudia Menzaghi; Federica Ortolani; Alessandra Rutigliano; Arianna Rotondo; Rita Fischetto; Elvira Piccinno; Maurizio Delvecchio
Journal:  Int J Environ Res Public Health       Date:  2022-09-03       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.